Stocks
Agios Pharmaceuticals (AGIO) EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -394.9 | -326.1 | -337.7 | -380.5 | -384.9 | 702.6 | ||
| Changes by years, y/y, % | +9% | -17% | +4% | +13% | +1% | +1.2% | |||
Agios Pharmaceuticals. EBITDA US GAAP, bln rub
Agios Pharmaceuticals. EBITDA US GAAP, changes, %
Agios Pharmaceuticals. EBITDA US GAAP, sum by quarters, bln rub
Agios Pharmaceuticals (AGIO) EBITDA US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EBITDA, bln rub | ? | -99.3 | -104.9 | -90.7 | -104.2 | 1 002 | 702.6 | |
| Changes by years, y/y, % | +6% | -53% | +0% | +11% | -1 110% | |||
| Changes by quarters, q/q, % | +6% | +6% | -13% | +15% | -1 062% | |||
